Pre-eclampsia
Also known as: Preeclampsia, Pre-eclamptic toxaemia, Proteinuric pregnancy hypertension, Postpartum pre-eclampsia
Pre-eclampsia is a multisystem hypertensive disorder occurring after 20 weeks' gestation or postpartum, defined by de novo hypertension and concurrent organ dysfunction (e.g., proteinuria, hepatic involvement). As a biomedical emergency with high risk of maternal and fetal morbidity, it necessitates immediate obstetric management. Acupuncture and Chinese herbal medicine are not indicated for treatment and must not delay conventional interventions including antihypertensives, magnesium sulphate for seizure prophylaxis, or delivery. This reference is for referral purposes; TCM recovery patterns are for adjunctive symptom support only following medical stabilisation and clearance. Cited research includes laboratory studies on taVNS, unvalidated algorithms for gestational insomnia, and observational data on postpartum cardiovascular health; these do not establish clinical efficacy for pre-eclampsia. Safety protocols constitute clinical guidance for the practitioner.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to the home blood-pressure monitoring protocol prescribed by the obstetric team, documenting all readings and observing established escalation thresholds.
- •Maintain all prescribed pharmacological regimens; consult the treating physician or pharmacist before initiating any supplements or over-the-counter medications.
- •Secure domestic support for neonatal care and nutritional requirements; ensure adequate rest and avoid fluid restriction, restrictive dieting, or strenuous physical exertion unless medically cleared.
- •Attend all scheduled early post-discharge reviews and the 6–12-week postpartum consultation to address long-term cardiovascular risk and ongoing blood pressure management.
Cautions & Contraindications
- •Suspected, active or recurrent pre-eclampsia is a reason to defer acupuncture, herbs and taVNS and obtain urgent obstetric care. The supplied taVNS research is in rats and cells, not evidence of human efficacy or safety; it cannot justify clinical use for this emergency.[]
- •Do not reduce antihypertensives or relax cardiovascular follow-up because symptoms improve with supportive care. The observational postpartum study found persistent cardiovascular abnormalities but did not test complementary treatments.[]
- •Recovery formulas are not automatically safe in pregnancy or lactation. Defer herbs with residual organ dysfunction, poorly controlled blood pressure or unresolved interaction concerns. Neither the preclinical study nor the insomnia algorithm establishes herbal safety; these are precautionary clinical restrictions rather than study-derived contraindications.[,]
- •Defer elective needling with thrombocytopenia, active bleeding, infection or medical instability; review anticoagulants and recent surgery before recovery care. The supplied evidence does not evaluate needling safety in these groups, so specialist clearance is required.[,]
When to reassess or seek care again
Acute or suspected disease: immediate obstetric assessment, not a complementary-care review interval. After complete stabilisation and clearance, reassess optional symptom support within 1–2 weeks using sleep duration, insomnia severity, fatigue score, daily functioning and the medically supervised blood-pressure record. Stop and refer immediately for any red flag or readings meeting the maternity team's escalation criteria; refer persistent fatigue or insomnia for medical assessment. Discontinue ineffective supportive treatment after 2–4 weeks. Maintain early postpartum monitoring, the 6–12-week review and clinician-directed longer-term cardiovascular surveillance; the supplied observational study followed participants to 12 months.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Molecular and cellular endocrinology · 2026
- Nature and science of sleep · 2026
- Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2026
- Cochrane Database of Systematic Reviews · 2015
Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.
- World Health Organization · 2008
Standard point locations used for the adjunctive points listed.
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
